Table of contents

Research Article

• Inflammatory predictors for the development of the adult respiratory distress syndrome. (1 October, 1995)

  P T Reid, S C Donnelly, C Haslett
• Childhood asthma: what is it and where is it going? (1 October, 1995)

  G Christie, P Helms
• Cystic fibrosis: transition from paediatric to adult physician's care. (1 October, 1995)

  L I Landau
• Cytokine expression in normal, atopic, and asthmatic subjects using the combination of sputum induction and the polymerase chain reaction. (1 October, 1995)

  C M Gelder, P S Thomas, D H Yates, I M Adcock, J F Morrison, P J Barnes
• The tar reduction study: randomised trial of the effect of cigarette tar yield reduction on compensatory smoking. (1 October, 1995)

  C Frost, F M Fullerton, A M Stephen, R Stone, A Nicolaides-Bouman, J Densem, N J Wald, A Semmence
• Comparison of fluticasone propionate and beclomethasone dipropionate on direct and indirect measurements of bronchial hyperresponsiveness in patients with stable asthma. (1 October, 1995)

  G P Bootsma, P N Dekhuijzen, J Festen, P G Mulder, C L van Herwaarden
• Short-term association between air pollution and emergency room visits for asthma in Barcelona. (1 October, 1995)

  J Castellsague, J Sunyer, M Sáez, J M Antó
• Exacerbations of asthma without sputum eosinophilia. (1 October, 1995)

  M O Turner, P Hussack, M R Sears, J Dolovich, F E Hargreave
• Abnormal myocardial repolarisation in response to hypoxaemia and fenoterol. (1 October, 1995)

  D G Kiely, R I Cargill, A Grove, A D Struthers, B J Lipworth
• Association of non-wheezing lower respiratory tract illnesses in early life with persistently diminished serum IgE levels. Group Health Medical Associates. (1 October, 1995)

  F D Martinez, D A Stern, A L Wright, L M Taussig, M Halonen
• Role of elevated plasma soluble ICAM-1 and bronchial lavage fluid IL-8 levels as markers of chronic lung disease in premature infants. (1 October, 1995)

  S Little, T Dean, S Bevin, M Hall, M Ashton, M Church, J Warner, J Shute
• Comparative effects of plasma exchange and pyridostigmine on respiratory muscle strength and breathing pattern in patients with myasthenia gravis. (1 October, 1995)

  P Goti, A Spinelli, G Marconi, R Duranti, F Gigliotti, A Pizzi, G Scano
• Relationship between cells obtained by bronchoalveolar lavage and survival in idiopathic pulmonary fibrosis. (1 October, 1995)

  K A Boomars, S S Wagenaar, P G Mulder, H van Velzen-Blad, J M van den Bosch
• Streptococcus milleri pulmonary disease: a review and clinical description of 25 patients. (1 October, 1995)

  C A Wong, F Donald, J T Macfarlane
• Cardiopulmonary exercise testing following bilateral thoracoscopic sympathicolysis in patients with essential hyperhidrosis. (1 October, 1995)

  M Noppen, P Herregodts, P Dendale, J D'Haens, W Vincken
• Repeaters count: a sentinel method for asthma outbreaks. Barcelona Soybean-Asthma Group. (1 October, 1995)

  J B Soriano, J M Antó, A Plasencia
• Review of the prescription of domiciliary long term oxygen therapy in Scotland. (1 October, 1995)

  D Morrison, K Skwarski, W MacNee
• Sleep-related breathing disorders. 5. Nasal continuous positive airway pressure treatment for obstructive sleep apnoea. (1 October, 1995)

  R R Grunstein
• Fallibility of transthoracic needle biopsy of anterior mediastinal masses. (1 October, 1995)

  L A Robinson, J R Dobson, P J Bierman
• Recall lung pneumonitis due to carmustine after radiotherapy. (1 October, 1995)

  P S Thomas, S Agrawal, M Gore, D M Geddes
• Management of residual thymic cysts in patients treated for mediastinal Hodgkin's disease. (1 October, 1995)

  A M el-Sharkawi, B Patel
• Commentary: lymphoma involving the mediastinum--challenges in diagnosis and management. (1 October, 1995)

  J A Ledermann
• Guidelines for care during bronchoscopy. (1 October, 1995)

  E A Millar, P d'A Semple
• Apnoea in Duchenne muscular dystrophy. (1 October, 1995)

  F Barbé, M A Quera-Salva, A G Agustí
• Chest physiotherapy in cystic fibrosis. (1 October, 1995)

  B A Webber